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Abstract
A/J mice bearing the H-2 allele IAk are highly susceptible to autoimmune myocarditis induced with cardiac myosin heavy chain (Myhc)-α 334–352, whereas B10.A mice carrying a similar allele IAk are relatively resistant,
suggesting that the generation of Myhc-α-reactive T cell repertoires is influenced by genetic background. To enumerate the precursor frequencies of Myhc-α-specific CD4 T cells, we sought to create IAk tetramers for Myhc-α
334–352. Tetramers were created using approaches that involve covalent tethering of individual peptide sequences
or exogenous loading of peptides into empty IAk molecules by peptide-exchange reaction. Using ribonuclease 43–
56 tetramers as controls, we demonstrated that by flow cytometry (FC), Myhc-α 334–352 tetramers specifically
bind myosin-reactive T cells. CD4 cells isolated from A/J mice immunized with Myhc-α 334–352 were used to
optimize conditions for tetramer staining, and neuraminidase treatment prior to tetramer staining permitted the
detection of Myhc-α-specific cells ex vivo. The reagents are useful tools for monitoring the frequency of Myhc-αreactive CD4 cells and to determine their pathogenic potential at a single cell level by FC.
Keywords: Cardiac myosin, MHC class II tetramers, Myocarditis, Autoimmunity, Mouse model
Abbreviations: DELFIA, dissociation-enhanced lanthanide fluoroimmunoassay; EAM, experimental autoimmune myocarditis; FC, flow cytometry; LN, lymph nodes; LNC, lymph node cells; Myhc-α, cardiac myosin
heavy chain-α; NASE, neuraminidase; OE-PCR, overlapping extension polymerase chain reaction; Tet, tetramer

1. Introduction
Several animal models of experimental autoimmune myocarditis (EAM) have been developed in various rodent species to study
the immunological mechanisms of myocardial injuries. Autoimmune myocarditis can be induced in susceptible animals by immunizing the animals with myocarditogenic epitopes of cardiac
myosin heavy chain (Myhc)-α; the disease is mediated primarily
by CD4 T cells (Liao et al., 1993; Donermeyer et al., 1995). The
disease-inducing epitopes of Myhc-α have been characterized in
mice and rats, notably Myhc-α 334–352 in A/J (H-2a), CBA/J

(H-2k) and B10.A (H-2k) mice; Myhc-α 614–643 in BALB/c (H2d) mice; and Myhc-α 1304–1320 in Lewis rats (RT1) (Neu et
al., 1987b; Kodama et al., 1990; Smith and Allen, 1991; Donermeyer et al., 1995; Pummerer et al., 1996). Myhc has two isoforms, Myhc-α and Myhc-β, which are expressed at different times
during development. Myhc-α is expressed in adult mice, whereas
Myhc-β is expressed in the fetus (Pummerer et al., 1996; Reiser
et al., 2001; Hill et al., 2002), suggesting that the T cell repertoire
of the Myhc-α form may have escaped tolerance mechanisms in
the thymus. The fact that myocarditis could be induced with only
Myhc-α but not Myhc-β raises a question whether susceptible mice
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have endogenously derived a Myhc-α-specific T cell repertoire,
which expands upon immunization with myosin.
Our studies involve A/J mice carrying the H-2 allele IAk
at the major histocompatibility complex (MHC) class II locus,
which are highly susceptible to EAM induced with Myhc-α 334–
352 (Donermeyer et al., 1995). In contrast, B10.A mice, which
also carry the IAk allele, are relatively resistant, suggesting that
both MHC and non-MHC genes contribute to susceptibility to
myocarditis (Neu et al., 1987b). To investigate these genetic differences, we created IAk tetramers for Myhc-α 334–352. Using
bovine ribonuclease (RNase) 43–56 tetramers as controls, we
demonstrated that Myhc-α 334–352 tetramers bind myosin-reactive cells with specificity, and the reagents are useful in detecting antigen-specific cells ex vivo.
2. Materials and methods
2.1. Mice
We used 6- to 8-week-old female A/J mice (H-2a), obtained
from the Jackson Laboratory (Bar Harbor, ME) and maintained in accordance with the guidelines of the University of
Nebraska-Lincoln.
2.2. Peptide synthesis and immunization procedures
Myhc-α 334–352 (DSAFDVLSFTAEEKAGVYK), and
RNase (VNTFVHESLADVQA) were synthesized on 9-fluorenylmethyloxycarbonyl chemistry (Neopeptide, Cambridge,
MA). All peptides were HPLC-purified (> 90%), identity was
confirmed by mass spectroscopy, and the peptides were dissolved in 1× PBS prior to use. For immunizations, peptides were
emulsified in complete Freund’s adjuvant (CFA) supplemented
with Mycobacterium tuberculosis extract to a final concentration
of 5 mg/ml, and administered subcutaneously in multiple sites
in the flank, footpads and sternal regions (100 μg/mouse) ( Donermeyer et al., 1995; Pummerer et al., 1996).
2.3. Creation of IAk constructs and expression of soluble IAk
monomers
Full length cDNAs representing IAk-α and IAk-β chains were
synthesized by RT-PCR using total RNA extracted from splenocytes stimulated with lipopolysaccharide and interferon-γ. To express soluble IAk molecules, transmembrane and cytoplasmic regions of IAk-α and IAk-β chains were replaced with the leucine
zipper domains of Fos and Jun transcriptional factors, respectively,
as described previously (Jang et al., 2003; Reddy et al., 2003).
We adopted two approaches to create IAk tetramers (Figure 1).
2.3.1. Derivation of tetramers using MHC class II-associated invariant chain peptide (CLIP) precursors
This approach involved covalent tethering of nt sequences of
CLIP 88–102 (gtgagccagatgcggatggctactcccttgctgatgcgtccaatg)
into the IAk-β construct such that upon expression, CLIP-linked
IAk proteins were obtained and tetramers could then be derived by exchanging CLIP with peptides of interest (Day et al.,
2003; Jang et al., 2003).

Figure 1. Strategies adopted to create IAk tetramers. A, derivation of tetramers from CLIP precursors. This approach involved covalent tethering of
the nt sequence of CLIP 88–102 into the IAk-β construct, followed by expression of soluble IAk molecules, biotinylation, thrombin cleavage, peptide loading and tetramerization. B, derivation of tetramers from peptide
precursors. In this approach, the nt sequences of Myhc-α 334–352 and
RNase 43–56 were covalently tethered into the IAk-β construct such that
IAk monomers containing the peptides were expressed directly. *Steps pertaining to CLIP precursors only.

IAk-α construct. First, we amplified the sequence of extracellular (E/C) domain from full length IAk-α cDNA, including the leader sequence, and the fragment was flanked
by Bam H I (5′) and Sal I (3′) sites. Second, a fragment
containing Fos and the BiR-A site for biotinylation was
synthesized by overlapping extension PCR (OE-PCR) to
include Sal I and Bam H I sites at 5′ and 3′ ends, respectively. The two fragments were then ligated using Sal I
and cloned into the Bam H I site in p10 dual promotercontaining pAcDB3 vector (BD Pharmingen, San Diego,
CA). The final IAk-α construct should then have contained, in the order of leader sequence: E/C domain, linker
(GGGGG), Fos (LTDTLQAETDQLEDEKSALQTEIANLLKEKEKLEFILAA), linker (SAGGG) and BiRA site (GLNDIFEAQKIEWHE).
IAk-β construct. Generation of the IAk-β construct required three cassettes. Cassette 1: PCR product was synthesized by OE-PCR to include leader sequence, Kpn I
site, CLIP 88–102 (VSQMRMATPLLMRPM), linker
(GGGGS), thrombin cleavage site (LVPRGS), and Bam
H I/linker (GSGSGS). Cassette 2: PCR product flanked
by Bam H I (5′) and Sal I (3′) sites, generated from fulllength IAk-β cDNA to include E/C region of IAk-β, was
obtained. Cassette 3: PCR product flanked by Sal I (5′) and
EcoR I (3′) sites representing the Jun sequence was amplified from IAs/myelin proteolipid protein (PLP) 139–151
construct (a kind gift from Dr. Vijay Kuchroo, Harvard
University, Boston, MA) ( Reddy et al., 2003). We ligated
cassettes 2 and 3 first, followed by cassette 1, and the fulllength construct thus derived was cloned into Bgl II and
EcoR I sites in pAcDB3 vector and sequenced.
2.3.2. Derivation of tetramers using peptide-precursors
In this approach, nt sequences of Myhc-α 334–352 and RNase
43–56 were tethered into the IAk-β construct, which permitted
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expression of peptide-linked monomers directly (Massilamany et
al., 2010). We used the IAk-α construct designed to obtain CLIP
precursors and modified the IAk-β construct by replacing the sequencesof CLIPandthrombincleavagesitewithMyhc-α334–352
(gatagtgcctttgatgtgctgagcttcacggcagaggagaaggctggtgtctacaag)
or RNase 43–56 (gtgaacacctttgtgcacgagtccctggctgatgtccaggcc).
The soluble IAk molecules were expressed in a Baculovirus
system using sf9 insect cells as described previously (Reddy et
al., 2003; Massilamany et al., 2010). Briefly, large-scale protein
production was performed in suspension cultures grown in spinner flasks attached to a sparger system (Bellco, Vineland, NJ)
at a multiplicity of infection 5. Cells were grown at a density
of 1 × 106 cells/ml in protein-free insect cell medium (SF900
III SFM, Invitrogen, Carlsbad, CA) for 3 to 5 days; the supernatants were concentrated using a Prep/Scale-TFF cartridge
(30 kDa) (Millipore, Bellerica, MA) and purified on anti-IAk
column (clone, 10–2.16). The protein elutes were concentrated
using Amicon ultra centrifugal filters (Millipore), and the protein yield typically ranged from 1 to 1.6 mg/l, regardless of IAk
constructs used.

dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA) buffer followed by DELFIA-enhancement solution (Perkin Elmer; Jang et al., 2003). Fluorescence intensity was measured at excitation/emission wavelengths of 340/615 nm using
a Victor3 Multi Label Plate Reader (Perkin Elmer). The optimized conditions were then used to generate tetramers utilizing biotinylated thrombin-cleaved IAk proteins and unlabeled
Myhc-α 334–352 or RNase 43–56.

2.4. Biotinylation, thrombin cleavage, peptide-exchange and
tetramerization

2.6. Measurement of recall responses

Biotinylation of IAk proteins was performed using biotin
protein ligase (Avidity, Denver, CO) at 30 °C in a reaction mixture containing 25 μg/10 nM of enzyme and 2.5 mg/ml of IAk
proteins (Reddy et al., 2003). After overnight incubation, free
biotin was removed by dialysis using ice-cold 1× PBS in multiple cycles over a period of 24 h.
Thrombin digestion was carried out at room temperature (RT)
for 2 h in 10 mM Tris HCl, pH 8.0, consisting of biotinylated
IAk proteins (1–2 mg/ml) and thrombin (20 units/mg) (Novagen, Madison, WI; Day et al., 2003; Jang et al., 2003). Thrombin-cleaved IAk proteins were resolved in 12% sodium dodecyl
sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) analysis and the migration pattern of the IAk-β chain was compared
with uncleaved IAk protein.
To validate conditions for peptide-exchange reactions, we
used dinitrophenol (DNP)-labeled Myhc-α 334–352 or RNase
43–56 in which a DNP tag was attached with one aminohexanoic acid linker at the N-terminus. The peptide purity (> 92%)
was verified by mass spectrometry and HPLC (Neopeptide; Day
et al., 2003; Jang et al., 2003). The conditions used for optimization included temperature, concentration of IAk proteins and
peptides (molar ratios, 3.3 μM:16.5 μM to 3.3 μM:132 μM) and
pH (5.5 to 7.5). Briefly, thrombin-cleaved, unbiotinylated IAk
monomers and DNP-Myhc-α 334–352 were incubated in duplicates in a peptide-exchange buffer containing sodium phosphate 50 mM, sodium chloride 100 mM, EDTA 1 mM and 1×
protease inhibitor overnight at RT. The reaction mixture was
coated onto 96-well white fluorescence plates (Nunc, Rochester, NY) in sodium phosphate 0.2 M, pH 6.8 overnight at 4 °C.
The plates were washed 5 times with 1× wash buffer (Perkin
Elmer, Waltham, MA) and blocked with casein 2% for 2 h at
37 °C. After washing as above, biotinylated anti-DNP was added
(0.25 μg) to each well (American Research Products, Belmont,
MA) and incubated for 1 h at RT. Europium-labeled streptavidin (SA) was then added to a concentration of 1 μg/ml of

2.5. Western blotting analysis
IAk-α and IAk-β chains contained the leucine zipper domains
of Fos and Jun, respectively (Reddy et al., 2003). The soluble
IAk molecules in the Baculovirus-infected supernatants were
resolved in 12% SDS-PAGE analysis and probed with rabbit
anti-Fos and anti-Jun polyclonal sera (a kind gift from Dr. Vijay Kuchroo) (Reddy et al., 2003). The Fos- and Jun-antibody
complexes were captured by goat anti-rabbit secondary antibody
conjugated with horseradish peroxidase, and the signals were
detected by enhanced chemiluminescence (ECL).

Ten days after immunization with Myhc-α 334–352 or RNase
43–56, mice were killed and the draining lymph nodes (LN)
(maxillary, mandibular, popliteal, axillary and inguinal) were
harvested. Single cell suspensions were prepared after lysing
the erythrocytes with 1× ammonium chloride potassium buffer
(Lonza, Walkersville, MD). Lymph node cells (LNC) were stimulated with the indicated peptides (0–100 μg/ml) at a cell density of 5 × 106 cells/ml for 2 days in growth medium containing 1× RPMI supplemented with 10% fetal calf serum (FCS),
1 mM sodium pyruvate, 4 mM l-glutamine, 1× each of non-essential amino acids and vitamin mixture, and 100 U/ml penicillin–streptomycin (Lonza). Cultures were then pulsed with
1 μCi of tritiated 3[H] thymidine per well; 16 h later, proliferative responses were measured as counts per minute (cpm) using
the Wallac liquid scintillation counter (Perkin Elmer; Reddy et
al., 2003; Massilamany et al., 2010).
2.7. IAk tetramer staining
IAk/Myhc-α 334–352 and RNase 43–56 tetramer staining
was performed by three- or four-color flow cytometry (FC)
as we have previously described (Massilamany et al., 2010).
LNC obtained from mice immunized with Myhc-α 334–352
or RNase 43–56 were restimulated with the corresponding
peptides (50 μg/ml), and after 2 days growth medium containing interleukin (IL)-2 was supplemented. Viable lymphoblasts were harvested on day 5 poststimulation by Ficoll-density gradient centrifugation and the cells were maintained in
IL-2 medium. Tetramer staining was performed by incubating
the cells with IAk/Myhc-α 334–352 or RNase 43–56 tetramers
conjugated with phycoerythrin (PE) in growth medium, pH 7
to 8.2, at 4 °C, 37 °C or RT for 0.5 to 3 h. Cells were washed
twice with 5 ml of 1× PBS and incubated with anti-CD4, antiCD25 or anti-CD40 ligand (CD40L) (eBioscience, San Diego,
CA), and 7-aminoactinomycin D (7-AAD; Invitrogen) on ice
for 20 min. After washing as above, cells were acquired by a
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flow cytometer (FACScan or FACSCalibur, BD Biosciences,
San Diego, CA), and the frequency of tetramer (tet)+ cells was
then enumerated by using Flow Jo software (Tree Star, Ashland, OR) in the live (7-AAD−) population. Tetramer staining
was optimized with respect to concentration of tetramers, duration, temperature, pH and the amount of FCS in the staining
medium. The reaction conditions for each of the parameters
were as follows: concentration of tetramers, and temperature
(RT for 3 h, FCS 2.5%, pH 7.6); duration (RT, FCS 2.5%, pH
7.6); pH (RT for 3 h, FCS 2.5%) and amount of FCS (RT for
3 h, pH 7.6).

7.6. Cells were washed with 1× BD IMag buffer and incubated
with anti-PE magnetic particles for 30 min at 4 °C. The antiPE-bound tet-PE+ cells were then enriched using IMag as recommended (BD Biosciences). Cells were stained with anti-CD4
and 7-AAD and acquired by a flow cytometer (FACSCalibur,
BD Biosciences) and the percentages of tet+CD4+ cells were
then enumerated in the live (7-AAD−) subset using Flow Jo software. To enrich tet+ cells from in vitro expanded cultures, viable
lymphoblasts harvested on day 8 poststimulation with Myhc-α
334–352 were used for magnetic separation as described above.

2.8. Effect of neuraminidase (NASE) on IAk/tetramer staining

3. Results

Myhc-α 334–352 reactive cell cultures were prepared from
A/J mice as above and the cells were maintained in IL-2 medium for 2 weeks. Cells were then treated with or without NASE
(0.7 units/ml) (Type X from Clostridium perfringens, Sigma-Aldrich, St. Louis, MO) in serum-free 1× DMEM for 45 min at
37 °C at a density of 1 × 107 cells/ml ( Reddy et al., 2003). After washing once with 5 ml of 1× PBS, cells were stained with
tetramers, anti-CD4 and 7-AAD and acquired by FC. Tet+ cells
were analyzed in the live (7-AAD−) CD4 subset.

3.1. Creation of IAk tetramers
IAk tetramers were created utilizing CLIP or peptide precursors (Figure 1). The IAk constructs corresponding to each approach were designed and successfully expressed in a Baculovirus system (Figure 2). We confirmed the identity of IAk-α and
IAk-β chains by Western blotting analysis by testing anti-Fos

2.9. Detection of Myhc-α 334–352-reactive CD4 cells by IAk tetramer staining ex vivo
A/J mice were immunized with Myhc-α 334–352 in CFA
twice with an interval of 1 week. After 7 days, the mice were
killed and LNC were prepared and used to determine the effect
of NASE on T cells. LNC were treated with or without NASE
as above followed by staining with CD4, CD69, CD25, CD44
and CD62 ligand (CD62L) antibodies and 7-AAD. After acquiring the cells by FC, percentages of each marker were determined in the live (7-AAD−) CD4 subset. For tetramer analysis, LNC were obtained from a pool of draining LN obtained
from three to five mice in each experiment. CD4 cells were enriched to a purity of more than 95% by negative selection based
on magnetic separation using IMAG according to the manufacturer’s recommendations (BD Biosciences). After treating the
cells with or without NASE as above, cells were incubated with
tetramers (30 μg/ml) for 3 h at RT in growth medium, pH 7.6,
supplemented with FCS (2.5%). Cells were washed twice with
5 ml of 1× PBS and stained with anti-CD4, anti-CD25, and
7-AAD and acquired by a flow cytometer (FACSCalibur, BD
Biosciences). The live (7-AAD−) CD25+ cells were gated first
in relation to forward scatter (FSC) and in which tet+ cells were
determined corresponding to CD4 subset.
2.9.1. Enrichment of tet+ cells by magnetic separation
Tetramer-positive cells were enriched using anti-PE magnetic
particles as described previously (Day et al., 2003; Jang et al.,
2003). Briefly, A/J mice were immunized with Myhc-α 334–352
in CFA twice with an interval of 1 week. Seven days after the
second immunization, draining LN were pooled from groups
of three to five mice each and LNC were obtained. CD4 cells
were enriched to a purity of more than 95% (as described in Section 2.9) and stained with PE-conjugated IAk tetramers (30 μg/
ml) for 3 h at RT in growth medium containing 2.5% FCS, pH

Figure 2. Derivation of IAk tetramers. A, IAk protein expression. IAk constructs representing the extracellular domains of IAk-α and IAk-β chains
were designed to include Fos and Jun sequences, respectively, and the soluble IAk proteins were expressed in Baculovirus using sf9 insect cells. After purifying the monomers on an anti-IAk column (10-2.16), the identity
of IAk-α and IAk-β chains was verified by Western blotting analysis using
rabbit anti-Fos and anti-Jun polyclonal sera and peroxidase-conjugated antirabbit secondary antibody, and the signals were detected by ECL. B, thrombin cleavage. Biotinylated IAk monomers containing CLIP 88–102 were
digested with thrombin to release CLIP, and the proteins were resolved in
12% SDS-PAGE analysis and stained with Coomassie blue. C, multimerization of IAk monomers. IAk proteins were biotinylated using biotin protein ligase, and the free biotin molecules were removed by dialysis in 1×
PBS. Biotinylation was verified by mixing biotinylated proteins and SA at
the indicated molar ratios and the multimerized complexes were resolved
in 6% native PAGE analysis. Representative data from three individual experiments are shown.
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and anti-Jun polyclonal rabbit sera, and protein bands of expected sizes (IAk-α, ~ 40 kDa; IAk-β, ~ 30 kDa) were obtained
(Figure 2A). The CLIP-linked strategy required thrombin cleavage to facilitate the release of the CLIP from the IAk-β chain.
Thrombin at a concentration of 20 units/mg for 2 h at RT led
to complete cleavage as indicated by greater migration of IAk-β
chain, compared with the uncleaved protein (Figure 2B). For
initial validation, we sought to create tetramers utilizing peptide precursors, which involved biotinylation and multimerization of IAk monomers using fluorescent dye-labeled SA. The extent of biotinylation was confirmed by mixing biotinylated IAk
proteins with SA; the molar ratios of 4:1 to 8:1 resulted in the
formation of comparable amounts of higher molecular weight
complexes (Figure 2C). We chose a molar ratio of 4:1 to prepare tetramers for flow cytometric evaluation of antigen-specific cells using SA-PE.
3.2. IAk tetramers bind antigen-sensitized T cells with specificity
To determine the specificity of IAk tetramers, we used primary T cell cultures obtained from A/J mice immunized with
Myhc-α 334–352 or RNase 43–56. We verified that the animals
responded to the antigens based on tritiated 3[H] thymidine incorporation assay. Although RNase 43–56 was less immunogenic than Myhc-α 334–352, both peptides induced dose-dependent T cell responses (Figure 3A). For tetramer staining,
LNC were first stimulated with peptides and cultured in IL-2
contained medium. After 5 days, viable cells were harvested and
stained with Myhc-α 334–352 or RNase 43–56 tetramers, such
that one of the two tetramers served as control in its respective
antigen-sensitized cultures; the tet+ cells were enumerated by FC.
Myhc-α tetramers bound cells obtained from mice immunized
with Myhc-α 334–352 (1.95%), but not from those immunized
with RNase 43–56 (0.07%); the converse also was true of RNase
43–56 tetramers (RNase 43–56—0.63% and Myhc-α 334-352—
0.08%; Figure 3B). The lower frequency of RNase tet+ cells is
possibly due to the relatively poor response obtained in the immunized mice. To further verify the specificity of IAk tetramers,
we adopted a strategy of enriching tet+ cells using anti-PE magnetic particles (Day et al., 2003; Jang et al., 2003). Expectedly,
Myhc-α 334–352 tet+ cells were enriched antigen-specifically as
indicated by an increase in the number of Myhc-α 334–352 tet+
cells in the post-enriched fraction (4.01%) as opposed to 0.61%
in the pre-enriched fraction with a difference of ~ 6.6 fold between the two (Figure 3C). Such an increment was negligible
with RNase 43–56 tetramers. Taken together, the results suggest
that IAk tetramers specifically bind antigen-sensitized CD4 cells.
3.3. Optimized conditions for IAk tetramer staining
For routine applications of tetramers, it was critical to optimize conditions, and our goal was to enhance tetramer binding
without compromising specificity. We considered the parameters
of concentration, duration, temperature, pH and the composition of the tetramer staining medium in experiments involving
Myhc-α 334–352-reactive cells (Figure 4). We noted that the intensity of tetramer staining was enhanced in proportion to the
increased concentration of tetramers (10–60 μg/ml). Such an
enhancement was also evident when the duration for tetramer

Figure 3. Specificity of IAk/tetramer staining. A, proliferation response.
A/J mice were immunized with Myhc-α 334–352 or RNase 43–56 in CFA.
After 10 days, the mice were killed and LN from three to four mice were
pooled and single cell suspensions were prepared. LNC were stimulated
with the corresponding peptides for 2 days and, after pulsing with tritiated
3[H] thymidine during the last 16 h, proliferative responses were measured
as cpm. Mean ± SEM values from three individual experiments involving 3
to 4 mice in each are shown. B, specificity of IAk tetramers. LNC obtained
from immunized mice with Myhc-α 334–352 or RNase 43–56 (control) were
restimulated as above and the cells were maintained in IL-2 medium. Viable lymphoblasts were harvested on day 9 and stained with IAk/tetramers
and anti-CD4 and 7-AAD. After acquiring the cells by FC, tet+ cells were
analyzed in the live (7-AAD−) CD4 subset. Representative data from three
to five individual experiments each involving 3 to 4 mice are shown. C, enrichment of tet+ cells by magnetic separation. Lymphoblasts were harvested
from cultures stimulated with Myhc-α 334–352 on day 8 poststimulation
and stained with PE-conjugated Myhc-α 334–352 or RNase 43–56 tetramers followed by anti-PE magnetic particles and the anti-PE-bound fractions were enriched based on magnetic separation. The enriched fractions
were then washed and stained with anti-CD4 and 7-AAD and after acquiring the cells by FC, anti-PE-bound tet+ cells were analyzed. Data shown
represent two individual experiments each involving 3 to 4 mice.
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Figure 4. Optimization of reaction conditions for IAk tetramer staining.
Myhc-α 334–352-reactive T cells were used to optimize conditions for IAk
tetramer staining by FC involving tetramers, anti-CD4 and 7-AAD. The
reaction conditions were concentration of tetramers, duration of tetramer
staining, temperature of staining reactions, pH and concentration of FCS
in the staining medium. Shown are the percentages of tet+ cells in the live
(7-AAD−) CD4 subset. RNase 43–56, control. Representative data from two
individual experiments are shown.

binding was prolonged (0.5–3 h). Temperature had a significant
effect on tetramer binding: staining was negligible at 4 °C when
compared with 37 °C or RT. Although the intensity of tetramer staining was comparable at both RT and 37 °C (~ 1%), the
background staining for RNase 43–56 tetramers was least at RT.
Equivalent intensity of tetramer staining (~ 1%) was obtained
regardless of either pH (7 to 8.2) or the amount of FCS present in the tetramer staining medium. Based on these results, we
chose a concentration of 30 μg/ml of tetramers, 3 h duration,
RT, a medium containing 2.5% FCS and IL-2 (5 μM), and pH
7.6 as the ideal conditions for tetramer staining.
3.4. Myhc-α 334–352 tetramers preferentially stain unactivated
or rested cells
We and others have previously shown that MHC class II tetramers have a tendency to bind activated cells, and we sought to
verify whether IAk tetramers also share this feature (Cameron et
al., 2001; Novak et al., 2001b; Reddy et al., 2003; Reijonen et al.,
2003). Figure 5A shows that Myhc-reactive cells expanded progressively starting on day 4 poststimulation with Myhc-α 334–
352. In a similar analysis, Myhc-α 334–352 tetramers failed to
bind Myhc-α-reactive cells, nor was significant proliferation in
splenocytes obtained from immunized mice (data not shown).
We then enumerated the frequency of Myhc-α tet+ cells in relation to the activation status of antigen-sensitized cells. CD4 expression was upregulated in Myhc-α 334–352-reactive cells as indicated by the appearance of a CD4high population; in addition,

Figure 5. IAk/Myhc-α 334–352 tetramers preferentially stain activated cells.
A, time-course expansion of Myhc-α-reactive cells. LNC from immunized
mice were restimulated with Myhc-α 334–352 for 2 days and maintained
in IL-2 medium. Viable lymphoblasts were harvested on indicated days and
stained with tetramers, anti-CD4 or anti-CD25, and 7-AAD. Cells were acquired by FC, and the percentages of live (7-AAD−) tet+CD4+ cells were
then determined. Tetramer analysis was also performed in relation to CD4lowvs. CD4high (B), or CD25lowvs. CD25high subsets gated on CD4 cells (C).
RNase 43–56, control. Representative data from two to five individual experiments with 3 to 4 mice in each are shown.

Myhc-α 334–352 tetramers preferentially stained CD4high but
not CD4low cells (4.58% vs. 0.28%; Figure 5B). We next verified
tetramer binding in relation to CD25 expression and this was
determined by gating CD4high and CD4low subsets. As shown
in Figure 5C, Myhc-α 334–352 tetramers bound preferentially
to cells expressing CD25low (3.73%) as opposed to CD25high
cells (0.73%) within the CD4high subset and such a staining intensity was low in CD4low subset ( Figure 5C). The staining of
Myhc-α 334–352 tetramers was specific since there was negligible binding to RNase 43–56 tetramers. The facts that CD25 is
considered as an activation marker of T cells and that Myhc-α
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Figure 6. Specificity of IAk/Myhc-α 334–352 tetramers created based on peptide-exchange reaction. A, peptide-exchange reaction. The CLIP-cleaved
IAk monomers were loaded with Myhc-α 334–352 at 3.3 μM:66.6 μM ratio in peptide-exchange buffer, pH 5.5 to 7.5, overnight at RT. After blocking, biotinylated anti-DNP was added followed by europium-labeled SA in DELFIA buffer and DELFIA-enhancer, and fluorescence counts were measured.
Mean ± SEM values representing two individual experiments are shown. B, tetramer staining. The CLIP-cleaved biotinylated IAk monomers were loaded
with Myhc-α 334–352 or RNase 43–56 as above. Tetrameric complexes were then obtained by mixing peptide-loaded IAk monomers with PE-conjugated
SA at 4:1 molar ratio and used to stain Myhc-α-reactive cells by FC. Percentages of tet+ cells were then enumerated in the live CD4 subset (left panel).
Mean ± SEM values are shown (n = 3). The right panel shows the dot plot representation of tetramer staining.

334–352 tetramers bound predominantly to the CD25low but not
the CD25high subset suggest that the tetramers have a preference
to bind unactivated or rested antigen-specific T cells.
3.5. Validation of IAk tetramers derived from CLIP-precursors
One of the objectives of deriving tetramers from CLIP-precursors was to be able to create tetramers by loading the peptides of
interest exogenously into the CLIP-cleaved empty IAk molecules
(Novak et al., 2001a; Day et al., 2003; Jang et al., 2003). We optimized the conditions for peptide-loading in the IAk-binding assay, and performed peptide-exchange reactions at different molar
ratios (from 3.3 μM:16.5 μM to 3.3 μM:132 μM) and pH (from
5.5 to 7.5) between CLIP-cleaved, IAk molecules and Myhc-α
334–352. Based on preliminary experiments, 3.3 μM:66.6 μM
was an optimal ratio, and, combined with a pH range of 6.0–7.5,
resulted in comparable peptide loading (Figure 6A). We then
created tetramers by loading Myhc-α 334–352 or RNase 43–56
into biotinylated CLIP-cleaved IAk molecules followed by multimerization using SA-PE, and the reagents were used to stain
Myhc-α 334–352-reactive cells by FC. As shown in Figure 6B,
Myhc-α 334–352 tetramers generated under all the pH conditions stained myosin-reactive cells with specificity, but the tetramers prepared at pH 7.0 resulted in maximum staining intensity

(0.8%). The data prove that the CLIP precursors could be used
to create IAk tetramers to detect antigen-specific cells.
3.6. Binding of Myhc-α 334–352 tetramers do not correlate with
CD40L expression
It has been previously shown that CD40L can be used as a
marker of activated antigen-specific cells (Chattopadhyay et al.,
2005; Frentsch et al., 2005). We tested whether Myhc-α 334–
352 tetramers preferentially bind Myhc-α-specific cells expressing CD40L. We noted that CD40L-expressing cells were evident
3 days after stimulation with Myhc-α 334–352, the expression
of which progressively increased, reaching a peak on day 6 followed by a decline (Figure 7A). But the tetramer analysis revealed that only a fraction of these cells bound Myhc-α tetramers (tet+CD40L−, 0.67% vs. tet+CD40L+, 0.13%) ( Figure 7B).
Similar results were obtained when tetramer analysis was performed in relation to endogenous expression of CD40L based
on intracellular staining (data not shown). We also investigated
whether blocking CD40–CD40L interaction with CD40 blocking antibody (clone, IC10, eBioscience; Zhang et al., 2007; Baker
et al., 2008; Otani et al., 2011) during antigenic stimulation can
facilitate stabilization of CD40L such that tet+ cells can then be
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Figure 7. IAk/Myhc-α 334–352 tetramers stain only a fraction of CD40Lexpressing cells. A, time-course expansion of CD40L-expressing CD4 cells.
LNC harvested from immunized mice were restimulated with Myhc-α 334–
352 for 2 days and rested in IL-2 medium, and CD40L-expressing cells were
determined in the live CD4+ subset by FC. B, tetramer analysis. Cells were
harvested on day 8 poststimulation, stained with anti-CD40L followed by
tetramers, anti-CD4 and 7-AAD and acquired by FC. Percentages of tet+
cells were then analyzed in relation to CD40L expression within the live (7AAD−) CD4 subset. Representative data from three experiments are shown.

better correlated with CD40L-expression. This was not the case
as there were no significant differences in the expression levels
of CD40L in anti-CD40-treated vs. -untreated cells. Likewise,
treatment with CD40 blocking antibody did not improve tetramer binding (data not shown). Taken together, our data suggest
that binding of Myhc-α 334–352 tetramers does not correlate
with CD40L expression in antigen-stimulated cells.
3.7. Enumeration of the frequency of Myhc-α 334–352-reactive
cells ex vivo
MHC class II tetramers are useful tools to analyze antigenspecific CD4 cells at a single cell level, but their tendency to stain
activated cells limits the use of these reagents ex vivo. We previously had shown that the binding ability of IAs tetramers can
be enhanced by treating the cells with NASE prior to tetramer
staining, and we adopted this method to detect myosin-specific
cells ex vivo ( Reddy et al., 2003). First, Myhc-α-reactive T cells
were generated from immunized mice and the cells were rested
for 2 weeks in IL-2 medium. Viable cells were then treated with
or without NASE prior to tetramer staining and the tet+ cells
were enumerated by FC. As shown in Figure 8A, NASE treatment enhanced the detection of Myhc-α-specific cells by approximately 4.5 fold (3.2% vs. 0.68%). We used these conditions to
detect Myhc-α-reactive cells in the LNC obtained from immunized mice ex vivo. We noted that NASE activated the cells nonspecifically independent of antigen-stimulation as indicated by
the appearance of a distinct population composed of large granular cells in which CD69, CD62L, CD44 and, to a lesser degree,
CD25 were upregulated ( Figure 8B). Corresponding to these
markers, we evaluated tetramer staining in cells treated with or

et al. in

Journal

of

Immunological Methods 372 (2011)

without NASE and we found that CD25 was better suited to enumerate antigen-sensitized CD4 cells. Since we could not clearly
differentiate CD25low and CD25high subsets, tet+ cells were enumerated by gating the whole CD25 population. Figure 8C shows
that the detection of Myhc-α 334–352 tet+ cells increased approximately two-fold with NASE treatment (0.28% vs. 0.13%).
A similar trend was also noted with RNase tetramers, but to a
lesser degree (0.07% vs. 0.12%), and this level of background
staining persisted consistently. Nonetheless, as predicted, the enhanced sensitivity obtained with NASE treatment allowed us to
detect more Myhc-α-sensitized cells in immunized mice. Additionally, we also examined Myhc-α 334–352 tet+ cells in mice
that received CFA alone but the reactivity was low (~ 0.07%).
To further prove the specificity of Myhc-α 334–352 tetramers,
we enriched tet+ cells corresponding to Myhc-α 334–352 and
RNase 43–56 tetramers using anti-PE magnetic particles ( Figure 9). Expectedly, the enriched fraction contained 0.92% of
Myhc-α 334–352-reactive cells as compared with 0.21% prior to
enrichment with a difference of ~ 4 fold and reactivity to RNase
43–56 tetramers was minimal proving that IAk tetramers can be
used to enumerate the frequencies of antigen-specific cells ex vivo.
4. Discussion
We have described the generation of IAk tetramers that allowed us to detect cardiac myosin-specific CD4 cells in mice bearing the H-2 allele, IAk. Traditionally, limiting dilution analysis
and cytokine ELISPOT assay have been used to enumerate the
frequencies of antigen-specific cells, but low specificity and the
tedious nature of these assays limit their use for routine applications (Buckner et al., 2002; Mallone and Nepom, 2004; Carneiro et al., 2009). In contrast, the use of tetramers permits easy
and rapid detection including the phenotypic characterization
of antigen-sensitized cells at a single cell level by FC (Altman
et al., 1996; Massilamany et al., 2010).
Unlike class I tetramers, the creation of class II tetramers is
technically challenging and it requires stable expression of soluble monomers composed of MHC II-α and β chains. Class II
tetramers were originally created by tethering peptide sequences
covalently to the N-terminus of the class II-β chain, but this approach requires generation of tetramers for each peptide individually (Kozono et al., 1994; Altman et al., 1996). The newer
approach involves expression of empty class II molecules into
which peptides are loaded exogenously, thereby facilitating creation of tetramers utilizing a single recombinant virus (Novak
et al., 2001a; Kwok et al., 2002, Day et al., 2003; Jang et al.,
2003). Some empty class II molecules (e.g., DQ8) tend to aggregate, requiring protection of the peptide-binding site ( Jang et
al., 2003), but the derivation of tetramers from CLIP precursors
overcomes this disadvantage. Additionally, exogenous loading
allows peptides to bind MHC molecules in different registries
( Novak et al., 2001a; Day et al., 2003; Jang et al., 2003). We
adopted both peptide- and CLIP-tethered approaches to generate IAk tetramers, validating the reagents with Myhc-α-reactive
cells obtained from mice immunized with Myhc-α 334–352 using RNase 43–56 tetramers as controls.
First, we validated IAk tetramers derived from peptide precursors. By using two tetramers (Myhc and RNase) and two cell
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Figure 8. Enumeration of the frequency of Myhc-α 334–352-specific CD4 cells ex vivo. A, effect of NASE on tetramer binding. LNC from immunized mice
were restimulated with Myhc-α 334–352 for 2 days followed by resting in IL-2 medium for 2 weeks. Cells were treated with or without NASE, followed
by staining with tetramers, anti-CD4 and 7-AAD. After acquiring the cells by FC, tet+ cells were enumerated in the live (7-AAD−) CD4 subset. Data represents one of the three individual experiments. B, effect of NASE on T cells. A/J mice were immunized twice with Myhc-α 334–352 in CFA with an interval of 1 week. After 7 days, mice were killed and LN were harvested, and single cell suspensions were prepared. LNC were treated with or without NASE,
stained with indicated markers, anti-CD4 and 7-AAD and acquired by FC. Percentages of each marker were analyzed in CD4 subset gated on ‘G1 and
G2’ (n = 3). C, tetramer analysis ex vivo. LNC were obtained from mice immunized with Myhc-α 334–352 and CD4 cells were isolated by magnetic separation. After treating the cells with or without NASE, cells were stained with tetramers, anti-CD4, anti-CD25 and 7-AAD, and percentages of tet+ cells were
analyzed in the live (7-AAD−) CD25-expressing CD4 subset by FC. Data representing 3 individual experiments involving 3 to 5 mice in each are shown.

types that react specifically to Myhc-α 334–352 or RNase 43–
56, we demonstrated that IAk tetramers bind to antigen-sensitized cells with specificity. The conditions optimized for tetramer staining include concentration (30 μg/ml), duration (3 h),
temperature (RT), pH (7.6) and the amount of FCS in the staining medium (2.5%). We and others had previously reported similar conditions for IAs, IAg7, IAu and IAb tetramers, suggesting
that the tetramer reaction conditions for various IA alleles are
generally similar (Liu et al., 2000; Radu et al., 2000; Reddy et
al., 2003; Korn et al., 2007). We noted that the staining intensity increased proportionally with the increased concentration
of tetramers, but the concentration of 30 μg/ml was chosen to
conserve the reagent. Likewise, the specificity of Myhc-α 334–
352 tetramers was not affected by the presence or absence of
FCS in the staining medium, but this component was included
to keep the cells healthy in the staining reactions. Second, to
enhance versatility, we sought to create tetramers utilizing IAk/
CLIP precursors, which permitted generation of Myhc-α 334–
352 or RNase 43–56 tetramers by loading the peptides into CLIPcleaved empty IAk monomers. As previously shown (Harding
et al., 1991; Sette et al., 1992), we found that a pH range of 6.0
to 7.5 facilitated peptide loading into IAk molecules. Myhc-α
tetramers derived from these IAk/peptide complexes stained
Myhc-α-reactive cells with specificity, proving that the CLIP

precursors can be used to create tetramers easily, thus broadening the applications of IAk tetramers. However, it is to be noted
that the staining intensity obtained with the tetramers derived
from CLIP precursors was generally less than that observed with

Figure 9. Enrichment of tet+ cells ex vivo by magnetic separation. CD4
cells were enriched from mice immunized with Myhc-α 334–352 on day
14 postimmunization by negative selection based on magnetic separation.
Cells were then treated with NASE followed by staining with PE-conjugated
IAk tetramers and anti-PE magnetic particles. After enrichment, cells were
washed and stained with anti-CD4 and 7-AAD and acquired by FC and the
anti-PE-bound tet+ cells were then analyzed. Representative data from two
individual experiments involving a pool of 3 to 5 mice in each are shown.
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peptide-tethered tetramers. This may be due to the possibility
that some of the IAk molecules in tetramers made from CLIP
precursors might not have been loaded with the peptides as opposed to peptide-tethered tetramers in which every IAk molecule is embedded with a peptide.
In our previous experience with IAs tetramers, which were
created to detect PLP 139–151-specific CD4 cells in SJL mice,
we had noted that tetramer binding peaked between days 4 and
6 poststimulation with PLP 139–151, but the staining became
negligible by day 10 (Reddy et al., 2003). In contrast, convincing evidence of staining occurred with Myhc-α tetramers in
LNC stimulated with Myhc-α 334–352 for at least 4 days after
preparation. The staining increased progressively but persisted
even up to day 10. This observation is critical to note because
we generally use antigen-stimulated cells within 4 days after
activation for adoptive transfer experiments, and our data indicated that antigen-specific T cell expansion occurs rather slowly
in A/J mice. Whether such a slow expansion is a characteristic
of particular immunogens or mouse strains remains to be determined. Importantly, under similar conditions, we failed to obtain Myhc-α 334–352-responsive T cell cultures from splenocytes
harvested from immunized mice. Although it is expected that
antigen-sensitized T cells are more concentrated in draining LN
than in spleens, the lack of T cell responses in the latter implies
that the use of splenocytes is not a viable option to determine
antigen-specific T cell reactivity, at least for Myhc-α 334–352.
Our data suggest that the antigen-stimulated LNC but not splenocyte cultures maintained in IL-2 medium for approximately
8–10 days are better suited for functional studies in A/J mice.
We and others had previously shown that class II tetramers
have a greater tendency to bind activated cells (Cameron et al.,
2001; Novak et al., 2001b; Reddy et al., 2003; Reijonen et al.,
2003). Contrary to our expectations, we noted that Myhc-α tetramers showed a preference for rested or unactivated cells expressing low levels of CD25. Conceivably, because tetramer binding
requires high-affinity T cell receptor (TCR) interactions, cells
bearing low-affinity TCRs may fail to be detected by tetramers
(Mallet-Designe et al., 2003; Reddy et al., 2003; Vollers and
Stern, 2008). The lack of significant binding to the CD25high
subset suggests that the affinity of TCRs of Myhc-α-reactive
cells may differ between CD25lowtet+ and CD25hightet+ populations. Alternatively, the differential binding of tetramers to CD25low and CD25high subsets might be due to differences in TCR
clustering/densities or their organization in the respective populations. For example, TCR clustering was inversely correlated
with CD25 expression in the transgenic T cells bearing high-affinity TCRs specific to myelin basic proteins 1–9 (Pastor et al.,
2006). Likewise, in the CD8 T cell system involving hemagglutinin 533–541-specific TCRs, transient loss of tetramer binding
was noted in relation to increased expression of CD25 shortly
after antigen stimulation, and this phenomenon was ascribed
to change in the display or organization of TCRs (Drake et al.,
2005). Previously, it was shown that CD40L expression can be
used as a marker of antigen-specific cells (Chattopadhyay et al.,
2005; Frentsch et al., 2005); we therefore expected that binding
of Myhc-α tetramers would correlate with CD40L expression,
but this was not the case. This discrepancy could be due to the
fact that we performed tetramer analysis in relation to CD40Lexpression on day 8 poststimulation with Myhc-α 334–352, the
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time point at which tetramer staining intensity reached its peak
(Figure 5A), as opposed to 6 h at which CD40L expression was
examined previously (Frentsch et al., 2005). It should be noted
that Myhc-α tetramers cannot be used to stain cells immediately
after antigen stimulation for at least 4 days because of their inability to bind antigen-reactive cells with specificity. Therefore,
lack of correlation between tetramer binding and CD40L expression does not mean that CD40L-expressing cells are not
antigen-specific. Alternatively, the class II tetramers may be inherently limited in binding only to high-affinity TCR-bearing
cells, and the appearance of tet+CD40L+ and tet+CD40L− subsets may represent antigen-reactive cells containing high- and
low-affinity TCRs, respectively.
One objective of deriving tetramers is the ability to enumerate the frequency of antigen-specific cells ex vivo, obviating the
need to stimulate the cells in vitro. Accumulated literature suggests that class II tetramers bind activated cells, but not resting
cells, even though they are antigen-specific ( Cameron et al.,
2001; Novak et al., 2001b; Reddy et al., 2003; Reijonen et al.,
2003). This makes it difficult to accurately determine the frequencies of antigen-specific T cell repertoires. To overcome this
limitation, we adopted a strategy of exposing the cells to NASE
prior to tetramer staining ( Daniels et al., 2001; Reddy et al.,
2003), which facilitated detection of approximately two-fold
more with Myhc-α tet+ cells than those detected without NASE
in mice immunized with Myhc-α 334–352. The enhanced binding of Myhc-α tetramers obtained with NASE treatment may
be due to two mechanisms: 1) NASE may enhance adhesiveness between TCR and tetramers by removing sialic acid from
the cell surface, thereby reducing the net charge ( Krieger et al.,
1988; Daniels et al., 2001), or 2) NASE can nonspecifically activate T cells ( Krieger et al., 1988; Reddy et al., 2003). Since
activated cells generally can be bound better by class II tetramers, we activated LNC obtained from immunized mice transiently for 6–12 h with various polyclonal activators (such as
CD3, TCR and CD28 antibodies, phorbol 12-myristate 13-acetate/ionomycin, and superantigens), but none of these agents
enhanced either the sensitivity or specificity of Myhc-α-reactive
cells (data not shown). Although low, background staining with
RNase tetramers was consistently noted in ex vivo staining reactions. We chose the bovine sequence for RNase 43–56 as a control, and the bovine sequence is 92% similar to mouse RNase,
except that serine at position 50 in bovine RNase is substituted
with proline in the mouse. It has been shown that the naïve peripheral repertoires contain autoreactive T cells for various selfantigens ( Klein and Kyewski, 2000; Romagnani, 2006; RootBernstein, 2007). Whether RNase tet+ cells represent such a pool
is not known, and we did not pursue this aspect in our studies.
In summary, we have demonstrated that IAk/Myhc-α tetramers facilitate the detection of Myhc-α 334–352-reactive CD4
cells with specificity. The tetramers are helpful tools to characterize the appearance, disappearance and persistence of cardiac
myosin-reactive CD4 T cell repertoires in mice bearing the H-2/
IAk allele. These include A/J, B10.A, B10.BR and CBA/J mice,
which show varying degrees of autoimmune responses to cardiac myosin (Neu et al., 1987b; Smith and Allen, 1991; Donermeyer et al., 1995). For example, A/J, CBA/J and B10.BR
mice are highly susceptible to EAM and Coxsackievirus B3-induced myocarditis, whereas B10.A mice are relatively resistant
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(Wolfgram et al., 1986; Neu et al., 1987a; Neu et al., 1987b;
Leslie et al., 1990; Gauntt et al., 1995). Our data obtained with
the EAM protocol suggest that myosin-specific CD4 cells can
be reliably enumerated in LNC but not in splenocytes, and that
NASE treatment prior to tetramer staining facilitates detection
of antigen-specific cells ex vivo. From the practical stand point,
IAk tetramers could serve as useful tools to enumerate the precursor frequencies of antigen-specific cells in cultures expanded
in vitro since activation facilitates efficient binding of IAk tetramers. Because of this limitation, it is difficult to accurately analyze the frequencies of Myhc-α 334–352-specific cells ex vivo.
Acknowledgments — We thank Hongjiu Dai for his involvement
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